2016
DOI: 10.1007/s10048-016-0496-y
|View full text |Cite
|
Sign up to set email alerts
|

New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy

Abstract: We report the clinical and biochemical findings from two unrelated patients who presented with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy. Whole exome sequencing (WES) uncovered a homozygous mutation in the ATP8A2 gene (NM_016529:c.1287G > T, p.K429N) in one patient and compound heterozygous mutations (c.1630G > C, p.A544P and c.1873C > T, p.R625W) in the other. Only one haploinsufficiency case and a family with a homozygous mutation in ATP8A2 gene (c.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(47 citation statements)
references
References 14 publications
1
46
0
Order By: Relevance
“…Although these two categories of mutations display significant differences in levels of protein expression, they both can be considered as loss‐in‐function mutations since neither category displayed phospholipid activated ATPase activity. This is in agreement with clinical studies in which patients with these different missense mutations all show similar severe neurological phenotypes as found in patients homozygous for premature stop codons and frameshift mutations in the ATP8A2 gene (Alsahli et al, ; Martín‐Hernández et al, ; McMillan et al, ; Onat et al, ).…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…Although these two categories of mutations display significant differences in levels of protein expression, they both can be considered as loss‐in‐function mutations since neither category displayed phospholipid activated ATPase activity. This is in agreement with clinical studies in which patients with these different missense mutations all show similar severe neurological phenotypes as found in patients homozygous for premature stop codons and frameshift mutations in the ATP8A2 gene (Alsahli et al, ; Martín‐Hernández et al, ; McMillan et al, ; Onat et al, ).…”
Section: Discussionsupporting
confidence: 89%
“…To date, seven missense mutations in ATP8A2 have been reported to cause severe neurological disorders in humans (Alsahli et al, ; Martín‐Hernández et al, ; McMillan et al, ). These include p.K429M, p.K429N, and p.W702R mutations in the phosphorylation domain (P domain), p.A544P and p.R625W mutations in the nucleotide‐binding domain (N domain), and the p.I376M and p.N917D mutations in the membrane domain of ATP8A2 (Figure a).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Mutations in ATP8A2 have been associated with severe neurological disorders in humans (19)(20)(21)(22). The isoleucine Ile-364, which is located in the M4 transmembrane segment, is highly conserved among P4-ATPases, and the I364M mutation (I376M in human) was identified as the cause of cerebellar ataxia, mental retardation, and disequilibrium syndrome (20).…”
Section: Resultsmentioning
confidence: 99%
“…Synonymous variants were not considered. Following their respective analysis pipelines, 15 , 16 , 17 , 18 participating centers generated a list of candidate variants filtered against variants from public databases according to modes of inheritance, then compared their results through international research networks and variant databases. 19 , 20 …”
Section: Main Textmentioning
confidence: 99%